Vitamin C for Postoperative Knee Pain
(PROVISION Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the drug Vitamin C for reducing postoperative knee pain?
Is Vitamin C safe for use in humans, particularly for postoperative knee pain?
Vitamin C is generally considered safe for use in humans, including in the context of postoperative care. It is an important antioxidant and has been associated with improved bone health and reduced postoperative pain in various studies. However, more high-quality human trials are needed to confirm its safety and optimal dosage in specific surgical settings.12346
How does the drug Vitamin C differ from other treatments for postoperative knee pain?
Vitamin C is unique because it is an antioxidant that can reduce pain and the need for opioids (strong painkillers) after surgery, especially when given intravenously (through a vein). This makes it different from standard pain treatments that often rely on medications like opioids, which can have more side effects.12346
What is the purpose of this trial?
Phase II Multicentre, pilot, parallel-group, blinded, 1:1 randomized controlled trial to determine the feasibility of conducting a larger definitive trail of using vitamin C to reduce persistent pain in patients undergoing total knee arthroplasty surgery.
Research Team
Jesse I Wolfstadt, MD
Principal Investigator
Mount Sinai Hospital; Department of Surgery
James Khan, MD
Principal Investigator
University Health Network; Department of Anesthesia and Pain Medicine
Raman Mundi, MD
Principal Investigator
Holland Orthopedic and Arthritic Centre
Harman Chaudhry, MD
Principal Investigator
Holland Orthopedic and Arthritic Centre
Eligibility Criteria
This trial is for adults over 18 who are having knee replacement surgery because of severe arthritis. It's not for those with knee replacements due to infection, fractures, certain autoimmune conditions, or if they're pregnant. Participants must be able to follow up and fill out questionnaires in the study language.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 2000 mg of vitamin C orally within 4 hours of surgery, followed by 500 mg twice daily from post-operative day 1 to day 56
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments of pain, opioid consumption, and quality of life
Treatment Details
Interventions
- Placebo
- Vitamin C
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mount Sinai Hospital, Canada
Lead Sponsor
University Health Network, Toronto
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
The Arthritis Society, Canada
Collaborator